Boston Scientific to acquire Silk Road Medical for $1.2bn to enhance stroke prevention capabilities

Boston Scientific Corporation (NYSE: BSZ) has announced its definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for $27.50 per share, reflecting an enterprise ... Read More